A global study, in which the LDI participated, has identified a specific gene variant that protects against severe infection by COVID-19.
Dr. Roderick McInnes, who recently stepped down as Director of the Lady Davis Institute, has been promoted to Officer of the Order of Canada.
Results of COVID-19 tests are available faster than ever, now that new equipment is performing the automated, molecular tests at the JGH.
Dr. Stephen Robbins has been appointed Director of the Lady Davis Institute, effective January 2021.
A ground-breaking new study has succeeded in compiling an “atlas” of genetic factors that are associated with estimated bone mineral density, one of the most clinically relevant factors in diagnosing osteoporosis.
The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.
The age of 90 seems to be a watershed time of life, when genes begin to play an increasingly important role in enabling some people to live to 100 or beyond.
It is unjustified and potentially harmful to screen women for genes whose connection to breast cancer has yet to be proven, says an international team of leading geneticists and oncologists.